Actos Now for the prevention of diabetes (ACT NOW) study
نویسندگان
چکیده
منابع مشابه
Actos Now for the prevention of diabetes (ACT NOW) study
BACKGROUND Impaired glucose tolerance (IGT) is a prediabetic state. If IGT can be prevented from progressing to overt diabetes, hyperglycemia-related complications can be avoided. The purpose of the present study was to examine whether pioglitazone (ACTOS) can prevent progression of IGT to type 2 diabetes mellitus (T2DM) in a prospective randomized, double blind, placebo controlled trial. MET...
متن کاملPrevention of Diabetes With Pioglitazone in ACT NOW
We examined the metabolic characteristics that attend the development of type 2 diabetes (T2DM) in 441 impaired glucose tolerance (IGT) subjects who participated in the ACT NOW Study and had complete end-of-study metabolic measurements. Subjects were randomized to receive pioglitazone (PGZ; 45 mg/day) or placebo and were observed for a median of 2.4 years. Indices of insulin sensitivity (Matsud...
متن کاملDo not wait, act now.
See related article, pages 3213–3217. Utilizing a population-based study1 Dr Majersik and her coworkers provide excellent data on stroke patient arrival times in a community without academic centers. Because most patients present after 3 hours from stroke onset—the ratio in their study is 62% to 69% of patients— the idea of Majersik and her coworkers is to extend the time window beyond 3 hours ...
متن کاملThe Time to Act is Now.
As images of beheaded American journalists James Foley and Steven Sotloff are seared into our consciousness, we would do well to honor their memories by recalling that they saw it as their mission to alert the world to the horrors committed by the fanatical Islamist terrorist group ISIS in Syria and Iraq: Children forced to view crucifixions and beheadings, women bartered, sold and raped, priso...
متن کاملGenetic enhancement: plan now to act later.
All three main articles in the issues of the Kennedy Institute of Ethics Journal endorse the view that genetic enhancement should be permitted, including human germ-line genetic enhancement. However, unregulated, wealth-based access to genetic enhancement in general, and germ-line enhancement in particular, would create intolerable risks for society. Although there are a number of practical pro...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: BMC Endocrine Disorders
سال: 2009
ISSN: 1472-6823
DOI: 10.1186/1472-6823-9-17